Utilization and costs of epidermal growth factor receptor mutation testing and targeted therapy in Medicare patients with metastatic lung adenocarcinoma

• Main Authors: Chan Shen (Author), Rolfy A. Perez Holguin (Author), Eric Schaefer (Author), Shouhao Zhou (Author), Chandra P. Belani (Author), Patrick C. Ma (Author), Michael F. Reed (Author)
• Format: Book
• Published: BMC, 2022-04-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Abstract Background Guidelines in 2013 and 2014 recommended Epidermal Growth Factor Receptor (EGFR) testing for metastatic lung adenocarcinoma patients as the efficacy of targeted therapies depends on the mutations. However, adherence to these guidelines and the corresponding costs have not been wel...